Qualitative interviews reveal preferences and treatment goals for long-acting injectables in bipolar I disorder, suggesting importance of discussions in healthcare settings.
Participants were positive about a potential transition to an LAI given once every 2 months. As each participant group has unique preferences for LAIs and treatment goals, these should be discussed during healthcare interactions to ensure that targeted disease management goals are met.
No takes yet. Share an insight, caveat, or question.
Tohen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: